Related Experiment Video
Updated: Mar 15, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
The path ahead for MD/PhD programs in Canada Commentary on Jones et al.
1. norman.rosenblum@sickkids.ca.
This study examines Canadian MD/PhD programs, offering insights into these crucial physician-scientist training pathways. It highlights recent contributions from leaders in the Clinical Investigator Trainee Association of Canada (CITAC).
Area of Science:
- Medical Education
- Physician-Scientist Training
Background:
- Limited published data exists on Canadian MD/PhD programs.
- The Clinical Investigator Trainee Association of Canada (CITAC) plays a role in advancing physician-scientist training.
- Understanding these programs is vital for medical research and innovation.
Purpose of the Study:
- To contribute to the understanding of Canadian MD/PhD Programs.
- To document the efforts and productivity of leaders within these programs.
- To build upon previous publications by CITAC leaders.
Main Methods:
- The study is a review and synthesis of existing knowledge and contributions.
- It builds upon a series of publications by leaders in the field.
- Analysis of the current landscape of Canadian MD/PhD training.
Main Results:
- The paper provides a current overview of Canadian MD/PhD programs.
- It highlights the contributions of key individuals and organizations.
- Identifies a need for continued focus on physician-scientist training in Canada.
Conclusions:
- The authors commend the efforts and productivity in advancing Canadian MD/PhD programs.
- Further research and publications are encouraged to enhance understanding.
- Continued support for physician-scientist training is essential for Canadian medical research.
Related Concept Videos
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Genomics
Pharmacogenomics: Identification of New Drug Targets

